1 – 28 of 28
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Getting a Cryo-EM structure of β2AR-Gi1v1, for a better understanding of GPCR-G protein selectivity
(
- Master (Two yrs)
-
Mark
Cloning, purification and optimization of the human mitochondrial pyruvate carriers
(
- Master (Two yrs)
- 2019
-
Mark
Keeping up the PICUP
(
- Master (One yr)
-
Mark
PRECLINICAL DRUG DISCOVERY AND DEVELOPMENT FOR A NOVEL ALZHEIMER’S DISEASE DRUG : - A stroy of an orphan -
(
- Master (Two yrs)
-
Mark
Cloning, Expression and Purification of the Mitochondrial Pyruvate Carrier
(
- Master (Two yrs)
- 2017
-
Mark
Host-pathogen interactions in chronic infections and the development of novel therapies
(
- Master (Two yrs)
-
Mark
Methods in post-translational modification studies: protein purification and chemical digestion optimization
(
- Master (Two yrs)
-
Mark
Production of the CD44 human receptor in Escherichia coli and study of its interactions with potential inhibitors.
(
- Master (Two yrs)
- 2016
-
Mark
PREPARATION OF CLASS I AND III RIBONUCLEOTIDE REDUCTASE (RNR) AND ROLE OF THE ATP-CONE DOMAIN
(
- Master (Two yrs)
-
Mark
Development of a Hepatitis B virus capsid as a nanocontainer and a carrier for protein delivery into cells
(
- Master (Two yrs)
- 2015
-
Mark
A Trick of the Tail: The Effect of Amyloid Formation on the pKa Values of α-synuclein
(
- Master (Two yrs)
-
Mark
The Effect of Protein Corona on Gold Nanoparticles Aggregation
(
- Master (Two yrs)
-
Mark
Evaluating Basigin promoter variants by CRISPR-Cas9 genome editing
(
- Master (Two yrs)
-
Mark
An investigation into the Nicotiana benthamiana XIP1;1 N-terminal region
(
- Master (Two yrs)
- 2014
-
Mark
Antibody fragments inhibiting amyloid beta-aggregation - a potential treatment for Alzheimer's disease
(
- Master (Two yrs)
-
Mark
Novel mannanases from industrially relevant microorganisms
(
- Master (Two yrs)
-
Mark
Evaluation of a miR-125a mimic using an established Luciferase assay and working towards a new model-system to study RNAi in Escherichia coli
(
- Master (Two yrs)
-
Mark
Characterization of EDC34, a C-terminal TFPI-2 derived peptide
(
- Master (Two yrs)
- 2013
-
Mark
Structural and functional analysis of violaxanthin de-epoxidase
(
- Master (Two yrs)
-
Mark
A crystallographic study of effector and substrate binding for the class III ribonucleotide reductase from Thermotoga maritima
(
- Master (Two yrs)
-
Mark
Production and Characterization of Mrp AntiporterComplex - The Evolutionary Progenitor of Complex I
(
- Master (Two yrs)
-
Mark
Crystallization and preliminary X-ray crystallographic studies on Moxarella IgD-binding (MID) 764 mutant protein from Moraxella catarrhalis
(
- Master (Two yrs)
- 2012
-
Mark
Chemokines regulate colon cancer metastasis
(
- Master (Two yrs)
-
Mark
Development of an Antigen-independent Affinity Assay to study the Binding of IgG to FcgammaR
(
- Master (Two yrs)
-
Mark
Exploring the effects of platinum compounds on RNA, adduct formation, thermal melting properties and siRNA down regulation capacity of gene targets associated
(
- Master (Two yrs)
-
Mark
An in vivo system for measuring solubility of proteins without activity in Escherichia coli
(
- Master (Two yrs)
-
Mark
Protein Stability, Folding and Design: Stabilization of scFv Protein through its reconstitution using a split GFB biosensor in vivo
(
- Master (Two yrs)
- 2011
-
Mark
Expression, purification and characterization of Violaxanthin De-epoxidase from Spinach
(
- Master (Two yrs)